After communicating and directly conserving with foreign pharmaceutical enterprises, DAV has found out the following concerns:
- Are foreign-invested enterprises importing pharmaceuticals entitled to use GSP standard-satisfying storage facilities of the third party to be eligible for the Certificate of Conformance to pharmaceutical business requirements - drug importation scope?
- Are representative offices of foreign companies involved in drug and pharmaceutical raw materials business entitled to recruit pharmaceutical sales representatives?
- Are representative offices of foreign pharmaceutical companies allowed to organize drug communication activities targeted at physicians and pharmacists through medical representatives or drug communication seminars or workshops?
- Are foreign-invested pharmaceutical enterprises exercising importing rights and their representative offices allowed to forming a partnership with domestic distributors in participating in price negotiations to bid to provide drugs for public medical establishments?
Please read detailed responses in the Official Dispatch No. 4338/QLD-PCD dated March 14, 2018.
>> CLICK HERE TO READ THE ARTICLE IN VIETNAMESE
1.446